Physician

Eugene Lyubashevsky, M.D.

According to 2025 Medicare claims, Eugene Lyubashevsky, M.D. (NPI: 1952372039) practices gastroenterology in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is FRANCISCAN PHYSICIAN NETWORK (NPI: 1225327984; TIN: 611630276) and primary practice location at 46360-0021. Lyubashevsky is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), participating under the MSSP model.

Lyubashevsky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 400 traditional Medicare patients, billed 1,262 HCPCS/CPT codes, and received $109,804 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 959 prescription claims across 278 beneficiaries totaling $159,605 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 7 records totaling $380. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $207,336 to $109,804. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $170,300 and ending at $159,605. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	540	2,020	$207,336
2016	564	1,820	$172,968
2017	508	2,043	$162,420
2018	497	1,929	$158,924
2019	564	2,282	$185,131
2020	462	1,868	$153,629
2021	460	1,652	$144,328
2022	411	1,463	$128,014
2023	451	1,604	$142,271
2024	400	1,262	$109,804

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	228	881	$170,300
2016	268	911	$229,322
2017	249	1,067	$353,128
2018	270	1,142	$220,515
2019	239	1,054	$155,695
2020	246	973	$164,979
2021	258	993	$227,595
2022	236	944	$105,640
2023	263	835	$153,582
2024	278	959	$159,605

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	124	125	$182
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	94	217	$87
45380	Biopsy of large bowel using a flexible endoscope	137	138	$49
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	111	121	$39
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	174	180	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	35	2,400	$44,756
Sucralfate	Sucralfate	119	3,246	$6,328
Mesalamine	Mesalamine	15	1,152	$4,538
Pantoprazole Sodium	Pantoprazole Sodium	281	21,173	$3,892
Cholestyramine	Cholestyramine (With Sugar)	37	1,319	$3,883

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$380	Olympus America Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eugene Lyubashevsky, M.D.?

Tedicare shows public-source Medicare data for Eugene Lyubashevsky, M.D. (NPI 1952372039), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eugene Lyubashevsky, M.D. have ACO affiliation data?

Eugene Lyubashevsky, M.D. is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550).

What billing organization is linked to Eugene Lyubashevsky, M.D.?

Eugene Lyubashevsky, M.D. is linked to FRANCISCAN PHYSICIAN NETWORK (billing NPI 1225327984) in the available physician profile data.

Does Eugene Lyubashevsky, M.D. have Open Payments data?

Eugene Lyubashevsky, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.